These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 20305584)
1. Myth and reality of pragmatic trials. Mohr P; Bitter I; Constant E; Jakovljević M; Jarema M; Pecenak J; Seifritz E; Svestka J; Sartorius N Psychiatr Danub; 2010 Mar; 22(1):2-3. PubMed ID: 20305584 [No Abstract] [Full Text] [Related]
2. The CATIE study and its implications for antipsychotic drug use. Janicak PG Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293 [No Abstract] [Full Text] [Related]
3. Schizophrenia: recent advances in psychopharmacology. Sharma T Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):194-8. PubMed ID: 8777500 [No Abstract] [Full Text] [Related]
4. Paliperidone (Invega) for schizophrenia. Med Lett Drugs Ther; 2007 Mar; 49(1256):21-3. PubMed ID: 17351558 [No Abstract] [Full Text] [Related]
5. Dose selection and comparator drugs in schizophrenia research. Kane JM J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828 [TBL] [Abstract][Full Text] [Related]
6. Factors which can make patients difficult to treat. Kane JM Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650 [No Abstract] [Full Text] [Related]
7. [Quotidien prescription: between references and reality]. Verdoux H Encephale; 2006 Jan; 32 Pt 2():S10-1. PubMed ID: 16800079 [No Abstract] [Full Text] [Related]
10. Pharmacologic treatment of adolescent and child schizophrenia. Young CM; Findling RL Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615 [TBL] [Abstract][Full Text] [Related]
11. The Clinical Antipsychotic Trials of Intervention Effectiveness: what did we learn? Boyd MA Arch Psychiatr Nurs; 2008 Feb; 22(1):56-8. PubMed ID: 18207059 [No Abstract] [Full Text] [Related]
12. [Psychopharmacotherapy in psychiatric nursing homes: myth and reality]. Krüninger U; Herpich S; Schreiber W Psychiatr Prax; 2004 Nov; 31 Suppl 1():S170-2. PubMed ID: 15570543 [TBL] [Abstract][Full Text] [Related]
13. Proceedings: Butaclamol in the treatment of schizophrenia--a comparison of two treatment methods. Imaz F; Ban TA; Lehmann HE Psychopharmacol Bull; 1976 Jan; 12(1):31-4. PubMed ID: 1826 [No Abstract] [Full Text] [Related]
14. New antipsychotic medications: do research results relate to clinical practice? MacEwan GW Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572 [TBL] [Abstract][Full Text] [Related]
15. [Priority for atypical antipsychotic drugs? Current studies clarify the issues]. Dose M Psychiatr Prax; 2007 Jan; 34(1):46-9. PubMed ID: 17265252 [No Abstract] [Full Text] [Related]
16. Antipsychotic effects of AL 1965. Sathananthan G; Mir P; Gershon S Curr Ther Res Clin Exp; 1976 May; 19(5):516-9. PubMed ID: 7435 [No Abstract] [Full Text] [Related]
17. Risperidone for chronic schizophrenia. Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777 [No Abstract] [Full Text] [Related]
18. [Problems in evaluating new antipsychotic drugs]. Fleischhacker WW Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969 [TBL] [Abstract][Full Text] [Related]
19. Quetiapine for schizophrenia. Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044 [No Abstract] [Full Text] [Related]
20. Overview of the findings from the European SOHO study. Suarez D; Haro JM Expert Rev Neurother; 2008 Jun; 8(6):873-80. PubMed ID: 18505352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]